We are live on !
Find out more
First Manhattan Portfolio holdings
AUM
$39.2B
Turnover
13.59%
1-Year Est. Return
21.04%
First Manhattan is an investment management firm founded in 1964 by David Gottesman, and it works mainly for high net worth individuals. Most of the assets it manages are in stocks, which its portfolio managers pick with a cautious, value-oriented approach. The firm also advises private funds focused on the banking industry and on companies that earn most of their revenue in China, along with two ETFs.
This Fund
S&P 500
This Quarter Est. Return
+4.58%
1 Year Est. Return
+21.04%
3 Year Est. Return
+83.94%
5 Year Est. Return
+115.5%
10 Year Est. Return
+416.22%
AUM
$16.3B
AUM Growth
+$739M
(+4.7%)
Cap. Flow
+$143M
Cap. Flow % of AUM
Cap. Flow %
0.88%
Top 10 Holdings %
Top 10 Hldgs %
40.58%
Holding
1,584
New
82
Increased
241
Reduced
411
Closed
94
Avg Time Held
2
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$104M |
| 2 |
AGN
Allergan plc
AGN
|
+$80.4M |
| 3 |
Pfizer
PFE
|
+$66.8M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$55.7M |
| 5 |
Comcast
CMCSA
|
+$41.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$43M |
| 2 |
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
|
+$40.4M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$38.6M |
| 4 |
American International
AIG
|
+$38.6M |
| 5 |
Microsoft
MSFT
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 34.81% |
| 2 | Healthcare | 15.2% |
| 3 | Industrials | 9.94% |
| 4 | Miscellaneous | 8.13% |
| 5 | Technology | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Berkshire Hathaway Class A
BRK.A
$1.25T
| $2.95B | 18.11% |
14,918
-192
| -1% | -$38.6M |
2013 Q2
10 quarters
|
|
2
Brookfield
BN
$93B
| $552M | 3.39% |
49,843,993
-381,535
| -0.8% | -$4.48M |
2013 Q2
10 quarters
|
|
|
3
Microsoft
MSFT
$3.88T
| $456M | 2.8% |
8,210,399
-567,090
| -6% | -$29.8M |
2013 Q2
10 quarters
|
|
4
Berkshire Hathaway Class B
BRK.B
$1.25T
| $348M | 2.14% |
2,635,109
+26,890
| +1% | +$3.61M |
2013 Q2
10 quarters
|
|
5
CVS Health
CVS
$115B
| $346M | 2.12% |
3,538,128
-94,869
| -3% | -$9.29M |
2013 Q2
10 quarters
|
|
6
AB InBev
BUD
$166B
| $311M | 1.91% |
2,489,242
-41,974
| -2% | -$5.08M |
2013 Q2
10 quarters
|
|
7
Wells Fargo
WFC
$258B
| $311M | 1.91% |
5,719,926
-316,667
| -5% | -$17.2M |
2013 Q2
10 quarters
|
|
8
Johnson & Johnson
JNJ
$685B
| $290M | 1.78% |
2,824,592
-30,344
| -1% | -$3.05M |
2013 Q2
10 quarters
|
|
|
9
American International
AIG
$43B
| $279M | 1.71% |
4,500,520
-632,302
| -12% | -$38.6M |
2013 Q2
10 quarters
|
|
10
H&R Block
HRB
$6.18B
| $257M | 1.58% |
7,718,665
+41,951
| +0.5% | +$1.49M |
2013 Q2
10 quarters
|
|
|
11
Perrigo
PRGO
$2.24B
| $257M | 1.58% |
1,775,596
+673,060
| +61% | +$104M |
2014 Q1
7 quarters
|
|
12
Zimmer Biomet
ZBH
$19.8B
| $253M | 1.55% |
2,539,802
-66,585
| -3% | -$6.51M |
2013 Q2
10 quarters
|
|
13
Apple
AAPL
$5.17T
| $242M | 1.49% |
9,211,488
+788,776
| +9% | +$22.5M |
2013 Q2
10 quarters
|
|
14
Danaher
DHR
$164B
| $223M | 1.37% |
3,571,846
+1,259
| +0% | +$78.8K |
2013 Q2
10 quarters
|
|
|
15
RTX Corp
RTX
$270B
| $222M | 1.37% |
3,679,428
-710,034
| -16% | -$43M |
2013 Q2
10 quarters
|
|
16
Aramark
ARMK
$14.1B
| $219M | 1.34% |
9,403,394
-274,666
| -3% | -$6.28M |
2014 Q2
6 quarters
|
|
17
Honeywell
HON
$71.1B
| $217M | 1.33% |
2,327,548
-40,166
| -2% | -$3.68M |
2013 Q2
10 quarters
|
|
|
AGN
18
DELISTED
Allergan plc
AGN
| $205M | 1.26% |
656,247
+270,206
| +70% | +$80.4M |
2014 Q1
7 quarters
|
|
19
Oracle
ORCL
$395B
| $175M | 1.07% |
4,782,052
-419,976
| -8% | -$16M |
2013 Q2
10 quarters
|
|
|
DISCK
20
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $164M | 1.01% |
6,498,737
-404,173
| -6% | -$11M |
2013 Q2
10 quarters
|
|
|
21
Comcast
CMCSA
$88.1B
| $163M | 1% |
5,777,892
+1,380,954
| +31% | +$41.6M |
2013 Q2
10 quarters
|
|
22
Gilead Sciences
GILD
$210B
| $156M | 0.96% |
1,544,177
+10,635
| +0.7% | +$1.11M |
2013 Q2
10 quarters
|
|
23
Philip Morris
PM
$309B
| $156M | 0.96% |
1,771,156
-1,811
| -0.1% | -$157K |
2013 Q2
10 quarters
|
|
|
JAH
24
DELISTED
JARDEN CORPORATION
JAH
| $126M | 0.78% |
2,212,840
+174,138
| +9% | +$8.73M |
2013 Q2
10 quarters
|
|
25
Accenture
ACN
$149B
| $125M | 0.76% |
1,192,251
-39,210
| -3% | -$4.14M |
2013 Q2
10 quarters
|
|
Similar funds
VARA
First Manhattan's Q4 2015 Portfolio in Review
As of Q4 2015, First Manhattan held 1,584 positions worth $16.3B, up 4.7% from $15.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
First Manhattan's Q4 2015 filing shows 82 new, 241 increased, 411 reduced and 94 closed positions. Its largest new stake was CSW Industrials: 918,159 shares worth $34.6M. The largest sale was RTX Corp, an estimated $43M.
By sector, the portfolio is most concentrated in Financials at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q4 2015 buy was CSW Industrials: 918,159 shares worth $34.6M.
- First Manhattan added most to Perrigo in Q4 2015, an estimated $104M increase.
- First Manhattan's biggest Q4 2015 reduction was RTX Corp, cutting an estimated $43M.
- First Manhattan fully exited COMCAST CORP SPL A (NEW) in Q4 2015, selling an estimated $40.4M.
- First Manhattan's ten largest holdings make up 41% of its $16.3B portfolio in Q4 2015.
- First Manhattan opened 82 new positions and closed 94 in Q4 2015.
- First Manhattan's portfolio value rose 4.7% quarter-over-quarter to $16.3B.
Based on First Manhattan's 13F filing for Q4 2015, filed 20 Jan 2016.